Concepedia

Catherine Jorand‐Lebrun

CJ

Statistics

Publications

13

Citations

534

H-Index

12

Active since

1995

Affiliations

Merck Serono S.A. (Switzerland)(Current)

Pierre Fabre (France)

Merck Serono S.p.A. (Italy)

Ono Pharmaceutical (United States)

Catherine Jorand‐Lebrun is an author at Merck Serono S.A. (Switzerland) specializing in pharmacology, medicinal chemistry, and ligand binding.

Publications per year

1995–2019

13

Publications

13

Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathway

Xiaoli Guo, Chikako Harada, Kazuhiko Namekata et al. · EMBO Molecular Medicine · 2010 · 146 citations · Full text

, , +12

Convergent Functional Genomics of Oligodendrocyte Differentiation Identifies Multiple Autoinhibitory Signaling Circuits

Rosanna Pescini Gobert, Lara Joubert, Marie-Laure Curchod et al. · Molecular and Cellular Biology · 2009 · 73 citations · Full text

, , +17

Optimization of the Central Core of Indolinone–Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists

Stefano Crosignani, Catherine Jorand‐Lebrun, Patrick Page et al. · ACS Medicinal Chemistry Letters · 2011 · 65 citations · Full text

, , +14

Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies

Ulrich Grädler, Dániel Schwarz, M. Blaesse et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 52 citations · Full text

, , +12

Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists

Catherine Jorand‐Lebrun, Bill Brondyk, Jing‐Jer Lin et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 40 citations · Full text

, , +16

1–5 of 13